Abera Bioscience

Abera Bioscience ROE

The Return on Equity (ROE) of Abera Bioscience (ABERA.SL) as of Oct 15, 2026 is -54.20 %. In the previous year, Return on Equity (ROE) was -12.71 % — a change of 326.50% (lower).

ROE

-54.20 %

YoY

326.50%

Last updated:

In 2025, Abera Bioscience's return on equity (ROE) was -54.20 %, a 326.50% increase from the -12.71 % ROE in the previous year.

The Abera Bioscience ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
-663.58 SEK
Jan 1, 2019
-60.70 SEK
Jan 1, 2020
-850.93 SEK
Jan 1, 2021
-31.44 SEK
Jan 1, 2022
-115.50 SEK
Jan 1, 2023
-295.67 SEK
Jan 1, 2024
-12.71 SEK
Jan 1, 2025
-54.20 SEK
The Abera Bioscience ROE history
YEARROEYoY
-54.20 %+326.50%
-12.71 %-95.70%
-295.67 %+155.98%
-115.50 %+267.39%
-31.44 %-96.31%
-850.93 %+1,301.81%
-60.70 %-90.85%
-663.58 %+784.40%
-75.03 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Abera Bioscience Stock analysis

What does Abera Bioscience do? Abera Bioscience AB is a biotechnology company based in Uppsala, Sweden, operating within the healthcare sector. The company focuses on the research and development of pharmaceutical products, particularly in the field of vaccine development. It utilizes a proprietary vaccine delivery platform to advance vaccine candidates toward late pre-clinical or early clinical stages. Abera Bioscience aims to identify licensing partners for further development of its vaccine candidates. The company's technology is primarily applied in the development of vaccines targeting pneumococci and immunooncology. Abera Bioscience has a small operational footprint, employing five full-time staff members. It completed its initial public offering (IPO) on February 24, 2021, and is listed under the ticker ABERA.SL with ISIN SE0015245097. The company's headquarters are located in Uppsala, and it operates primarily within the Nordic market. Its website is https://aberabio.com/. The company's activities are centered on advancing vaccine candidates through its platform technology, with an emphasis on strategic partnerships for subsequent development phases. Abera Bioscience is one of the most popular companies on Eulerpool.

ROE Details

Decoding Abera Bioscience's Return on Equity (ROE)

Abera Bioscience's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Abera Bioscience's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Abera Bioscience's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Abera Bioscience’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Abera Bioscience stock

Return on Equity (ROE) of Abera Bioscience is -54.20 % in 2025.

Return on Equity (ROE) of Abera Bioscience changed from -12.71 % to -54.20 %, representing a 326.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Abera Bioscience since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Abera Bioscience with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Abera Bioscience

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Abera Bioscience